YL Xia, WW Du, YP Li, Y Tao, ZB Zhang… - Journal of Chemical …, 2024 - ACS Publications
Nirmatrelvir, a pivotal component of the oral antiviral Paxlovid for COVID-19, targets the
SARS-CoV-2 main protease (Mpro) as a covalent inhibitor. Here, we employed combined …